Loading stock data…
$6.91-0.07 (-1.00%)
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally.
Emergent BioSolutions Inc. in the Healthcare sector is trading at $6.91 with a market capitalization of $346M. Wall Street consensus targets $11.00 (2 analysts), implying a +59.2% move over the next 12 months. The stock is currently 51% below its 52-week high of $14.06, remaining 17.8% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $226.80M↑ | $149.70M↑ | $143.80M↓ | $222.00M↑ | $130.30M |
| Gross Profit | $129.70M↑ | $77.70M↑ | $58.90M↓ | $136.10M↑ | $63.40M |
| Operating Income | $66.20M↑ | $10.50M↑ | -$15.70M↓ | $76.50M↑ | $1.60M |
| Net Income | -$180.20M↓ | $6.80M↑ | -$54.60M↓ | $51.20M↑ | -$12.00M |
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commerc...